Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
0.846
-0.028 (-3.20%)
At close: Dec 26, 2024, 4:00 PM
1.330
+0.484 (57.21%)
Pre-market: Dec 27, 2024, 5:36 AM EST
Evaxion Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 3.3 | 0.07 | - | - | - | - | |
| Gross Profit | 3.3 | 0.07 | - | - | - | - | |
| Selling, General & Admin | 7.87 | 10.35 | 8.21 | 6.25 | 5.67 | 2.65 | |
| Research & Development | 10.5 | 11.92 | 17.06 | 19.58 | 10.9 | 8.22 | |
| Operating Expenses | 18.37 | 22.27 | 25.26 | 25.83 | 16.57 | 10.86 | |
| Operating Income | -15.07 | -22.2 | -25.26 | -25.83 | -16.57 | -10.86 | |
| Interest Expense | -2.78 | -0.9 | -0.8 | -0.16 | -0.03 | -0.04 | |
| Interest & Investment Income | 5.67 | 0.15 | 0.01 | - | - | 0.01 | |
| Currency Exchange Gain (Loss) | -0.26 | -0.26 | 1.71 | 1.28 | 0.02 | 0.06 | |
| Other Non Operating Income (Expenses) | 0.28 | 0.28 | 0.4 | - | - | -1.18 | |
| Pretax Income | -12.15 | -22.92 | -23.94 | -24.71 | -16.58 | -12.02 | |
| Income Tax Expense | -0.69 | -0.79 | -0.77 | -0.18 | -1.56 | -0.83 | |
| Net Income | -11.46 | -22.13 | -23.17 | -24.53 | -15.02 | -11.2 | |
| Net Income to Common | -11.46 | -22.13 | -23.17 | -24.53 | -15.02 | -11.2 | |
| Shares Outstanding (Basic) | 5 | 3 | 2 | 2 | 2 | 1 | |
| Shares Outstanding (Diluted) | 5 | 3 | 2 | 2 | 2 | 1 | |
| Shares Change (YoY) | 78.19% | 15.64% | 21.27% | 26.29% | 11.10% | 7.55% | |
| EPS (Basic) | -2.48 | -8.09 | -9.80 | -12.58 | -9.73 | -8.06 | |
| EPS (Diluted) | -2.48 | -8.09 | -9.80 | -12.58 | -9.73 | -8.06 | |
| Free Cash Flow | - | -17.78 | -26.07 | -23.23 | -12.59 | -7.08 | |
| Free Cash Flow Per Share | - | -6.50 | -11.03 | -11.92 | -8.15 | -5.10 | |
| Gross Margin | 100.00% | 100.00% | - | - | - | - | |
| Operating Margin | -457.42% | -30406.85% | - | - | - | - | |
| Profit Margin | -347.83% | -30308.22% | - | - | - | - | |
| Free Cash Flow Margin | - | -24353.42% | - | - | - | - | |
| EBITDA | -14.87 | -21.8 | -24.91 | -25.49 | -16.46 | -10.78 | |
| D&A For EBITDA | 0.2 | 0.4 | 0.36 | 0.34 | 0.11 | 0.08 | |
| EBIT | -15.07 | -22.2 | -25.26 | -25.83 | -16.57 | -10.86 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.